Statin labelling may overstate adverse events
{{output}}
Overview of: Cholesterol Treatment Trialists' (CTT) Collaboration. Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials. Lancet 2026;407(10529):689-703. ... ...